OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.210
+0.010 (0.83%)
At close: Apr 28, 2026, 4:00 PM EDT
1.160
-0.050 (-4.13%)
After-hours: Apr 28, 2026, 5:54 PM EDT

OPKO Health Revenue

OPKO Health had revenue of $124.20M in the quarter ending March 31, 2026, a decrease of -17.18%. This brings the company's revenue in the last twelve months to $581.17M, down -15.70% year-over-year. In the year 2025, OPKO Health had annual revenue of $606.90M, down -14.90%.

Revenue (ttm)
$581.17M
Revenue Growth
-15.70%
P/S Ratio
1.51
Revenue / Employee
$266,760
Employees
2,275
Market Cap
918.47M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025606.90M-106.24M-14.90%
Dec 31, 2024713.14M-150.35M-17.41%
Dec 31, 2023863.50M-140.71M-14.01%
Dec 31, 20221.00B-770.52M-43.42%
Dec 31, 20211.77B339.31M23.64%
Dec 31, 20201.44B533.48M59.15%
Dec 31, 2019901.94M-88.33M-8.92%
Dec 31, 2018990.27M24.26M2.51%
Dec 31, 2017966.01M-151.48M-13.56%
Dec 31, 20161.12B625.75M127.25%
Dec 31, 2015491.74M400.61M439.63%
Dec 31, 201491.13M-5.41M-5.60%
Dec 31, 201396.53M49.49M105.19%
Dec 31, 201247.04M19.07M68.14%
Dec 31, 201127.98M-515.00K-1.81%
Dec 31, 201028.49M24.08M544.95%
Dec 31, 20094.42M-5.02M-53.20%
Dec 31, 20089.44M8.59M1,014.52%
Dec 31, 2007847.00K--
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Myriad Genetics824.50M
NeoGenomics727.33M
Veracyte517.15M
GeneDx Holdings427.54M
CareDx379.81M
Castle Biosciences344.23M
Fulgent Genetics322.67M
BillionToOne305.11M
Revenue Rankings